Letter: Treatment of Wilson's disease.
作者信息
Bucur I, Hasselgren K H
出版信息
Lancet. 1975 Dec 13;2(7946):1218. doi: 10.1016/s0140-6736(75)92721-x.
PMID:53713
Abstract
摘要
相似文献
1
Letter: Treatment of Wilson's disease.信件：威尔逊氏病的治疗
Lancet. 1975 Dec 13;2(7946):1218. doi: 10.1016/s0140-6736(75)92721-x.
2
Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.威尔逊病中青霉胺肾病的管理：一种新型螯合剂。
Lancet. 1969 Dec 27;2(7635):1401-2. doi: 10.1016/s0140-6736(69)90940-4.
3
Letter: Drugs for rare diseases.信件：用于罕见病的药物。
Br Med J. 1975 Sep 20;3(5985):701-2. doi: 10.1136/bmj.3.5985.701.
4
The effect of chelation therapy on the amino aciduria and peptiduria of Wilson's disease.螯合疗法对威尔逊病氨基酸尿症和肽尿症的影响。
J R Coll Physicians Lond. 1983 Apr;17(2):122-5.
5
Drug therapy in Wilson's disease.威尔逊氏病的药物治疗
J Am Optom Assoc. 1988 Jun;59(6):438.
6
Trientine for Wilson's disease.
Med Lett Drugs Ther. 1986 Jul 4;28(717):67.
7
Triethylene tetramine dihydrochloride in Wilson's disease.
Lancet. 1970 Oct 10;2(7676):775. doi: 10.1016/s0140-6736(70)90251-5.
8
[Triethylene tetramine in Wilson's disease].
Harefuah. 1986 Feb 16;110(4):178-9.
9
[Treatment of Wilson's disease using triethylenetetramine dihydrochloride (TETA)].
Cesk Gastroenterol Vyz. 1978 Dec;32(8):538-9.
10
[Treatment of Wilson's disease].[威尔逊氏病的治疗]
Cah Coll Med Hop Paris. 1968 Feb;9(2):184-7.
引用本文的文献
1
Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.曲恩汀在对D-青霉胺绝对不耐受的威尔逊病治疗中的制备及临床经验
Proc R Soc Med. 1977;70 Suppl 3(Suppl 3):10-2. doi: 10.1177/00359157770700S306.
Zotero 插件